Abstract
Dengue is a viral disease transmitted by mosquitoes. The rapid spread of dengue could lead to a global pandemic, and so the geographical extent of this spread needs to be assessed and predicted. There are also reasons to suggest that transmission of dengue from non-human primates in tropical forest cycles is being underestimated. We investigate the fine-scale geographic changes in transmission risk since the late 20th century, and take into account for the first time the potential role that primate biogeography and sylvatic vectors play in increasing the disease transmission risk. We apply a biogeographic framework to the most recent global dataset of dengue cases. Temporally stratified models describing favorable areas for vector presence and for disease transmission are combined. Our models were validated for predictive capacity, and point to a significant broadening of vector presence in tropical and non-tropical areas globally. We show that dengue transmission is likely to spread to affected areas in China, Papua New Guinea, Australia, USA, Colombia, Venezuela, Madagascar, as well as to cities in Europe and Japan. These models also suggest that dengue transmission is likely to spread to regions where there are presently no or very few reports of occurrence. According to our results, sylvatic dengue cycles account for a small percentage of the global extent of the human case record, but could be increasing in relevance in Asia, Africa, and South America. The spatial distribution of factors favoring transmission risk in different regions of the world allows for distinct management strategies to be prepared.
Author summary
The rate of disease emergence is increasing globally, and many long-existing diseases are extending their distribution ranges. This is the case for dengue, a global pandemic whose mosquito vectors are currently occupying ever-increasing numbers of regions worldwide. We updated the most complete global dataset of dengue cases available, and addressed the fine-scale analysis of the geographic changes experienced in dengue-transmission risk since the late 20th century. Our approach is the first to take into account the potential role of primates and sylvatic vectors in increasing the disease transmission risk in tropical forests. We built models that describe the favorable areas for vector presence and for disease occurrence, and combined them in order to obtain a novel model for predicting transmission risk. We show that dengue transmission is likely to spread to affected areas in Asia, Africa, North and South America, and Oceania, and to regions with presently no or very few cases, including cities in Europe and Japan. The global contribution of sylvatic dengue cycles is small but meaningful. Our methodological approach can differentiate the factors favoring risk in different world regions, thus allowing for management strategies to be prepared specifically for each of these regions.
Introduction
Dengue is a viral disease caused by the dengue virus, a group of four Flaviviridae serotypes [1]. The pathogen is principally transmitted by female mosquitoes of the genus Aedes to humans. In most cases, the pathogen causes mild illness, but is also known to cause flu-like symptoms, occasionally producing severe complications that are fatal [2]. More than 14,000 annual deaths are reported [3]. Dengue infections occur mainly in the Asian, African, and American tropics, but are being reported in many regions worldwide. The rapid spread of dengue is considered to represent a global pandemic threat [4].
The World Health Organization (WHO) reports that annual dengue cases have increased from approximately 500,000 in 2000 to approximately 4.2 million in 2019 [2]. This is considered an underestimation, however. Some authors have calculated that in 2013 between 58.4 million [3] and 96 million [5] yearly cases may have occurred worldwide, with many cases remaining unreported [6] and other cases being mistaken for similar pathologies [7, 8]. This confusion presents serious challenges for assessing the scale and geographic extent of the risk of disease transmission. However, distribution modelling has been used to map the global risk [5, 9].
Distribution models are useful not only for locating risk hotspots [10, 11] but also can be employed to inform prevention and mitigation strategies [12, 13] such as vector control measures, large-scale vaccination programmes, and traveller health-care advice. The first global dengue model produced at a high resolution described the geographic distribution of the risk of dengue transmission for the period 1960–2010 [5]. According to this model, as many as 390 million dengue infections in 128 countries were predicted [14], in contrast to the 4.2 million cases recorded in 2019 [2]. Annual records of dengue transmission [15] up to 2015 have provided data for the generation of risk models [9], which have also considered the environmental suitability for the arbovirus vectors Aedes aegypti and Ae. albopictus as covariables [16]. The integration of known and potential reservoir species in disease distribution models has already proved invaluable in pathogeography [17, 18] whereas the design of disease models that reflect complex interactions has benefited from biogeographical concepts and tools [18–20]. Thus, determining the distribution of infectious diseases needs to take into account the patterns of distribution of reservoirs and/or vectors [21, 22] and the ecology of the pathogen itself [23], which involves consideration of the environment as well as the human-geography context.
Dengue is principally an indirectly transmitted anthroponosis [24], humans being the main hosts and Aedes mosquitoes the main vectors. However, there are zoonotic “sylvatic” cycles in Africa and Asia where non-human primates are asymptomatically infected by the dengue virus, which is efficiently transmitted by the mosquito fauna in these regions [25–27]. There is evidence to suggest that the virus originated in monkeys, and that every one of its four serotypes was independently transmitted to humans in Africa and Asia [27, 28]. Transmission to humans from other primates appears to be infrequent, but they do occur. The scarcity of records might be a result of inadequate characterization of human exposure to sylvatic viruses [28]. In Africa and in Asia, there is high potential for the re-emergence of sylvatic dengue in the human transmission cycle as a result of deforestation, climate change, and vector geographic expansion [28]. While the existence of sylvatic dengue cycles has not been demonstrated in the Neotropic realms, there are reasons to foresee this possibility. This is because enzootic cycles based on American primates are involved in the diversification and transmission to humans of the yellow-fever virus, which shares vectors with the dengue virus [29–31].
Sylvatic cycles in South America appear to shape the evolutionary dynamics of recent yellow-fever-virus lineages, and are involved in the current re-emergence of this virus in Brazil [32]. In this country, dengue-virus-RNA has been found in sylvatic mosquitoes that are vectors of the yellow-fever virus [33]. In addition, dengue-virus infections in humans may have occurred in Bolivia in the absence of Ae. aegypti and Ae. albopictus [34], and different mammalian taxa have been infected with dengue-virus in French Guiana [35]. In light of these data, the possible presence of sylvatic dengue in the American continent is likely [28, 36].
Available models defining the global risk of dengue transmission have not included a zoonotic component. Although likely to be negligible at a global scale, sylvatic-dengue cycles may increase local or regional risk amplification, or represent a threat of dengue re-emergence or diversification. In addition, the global risk of transmission to humans is increasing as a consequence of globalization [37]. The pathogen is easily transported by travelers [38], and there is a rapid expansion of the main vectors [39, 40], which also evolve as they spread [41]. This means that modelling approaches involving temporal stratification are required in the production of dengue-risk maps, as well as a multidisciplinary approach as proposed by the international One Health initiative [42], to consider a multifactorial dynamic. Hence, evaluations of the current risk should take into account a combination of the inertia of past times, the advent of new factors capable of changing previous expectations, and the zoonotic dimension. Here, we adopt a multitemporal and multifactorial pathogeographic approach to analyzing the risk of dengue transmission to humans. We produced a risk model for the early 21st century, using available information on dengue cases up to 2019. We achieve this under the assumption that transmission between humans is (1) limited by the vector presence, (2) constrained by environmental conditions favoring vectorial capacity [43], (3) could be locally or regionally favored by the occurrence of enzootic cycles in the tropical forests, and (4) are experiencing an inter- and intra-continental spread that is subject to the growth of both virus’ and vectors’ ranges. Our aim is to contribute to the international health system with reliable forecasts on areas where dengue transmission between humans could increase in the near future, and with quantification and mapping of the contribution of sylvatic cycles.
Methods
Study area and time period
All spatially explicit data (i.e., dengue case records, mosquito occurrences, primate ranges, environmental variables) were projected onto a worldwide grid composed of 18,874 hexagonal units of 7,774 km2, built using Discrete Global Grids for R [44]. In this way, we prevented autocorrelation that could result from spatial dependence among very close occurrences [45].
As the dengue spatial trends are dynamic, the temporal extent for analysis purposes was divided into three periods: 1970–2000 (“the late 20th century”), 2001–2017 (“the early 21st century”), and 2018–2019. Pre-1970 records were not considered so as to limit our conclusions to a contemporary setting. Some milestones regarding the fight against arboviral diseases occurred circa 1970, such as the re-infestation of Latin America with Ae. aegypti, the main vector of the dengue virus, after 50 years of eradication efforts [46]. The use of DDT was suspended in the late 1960s in several countries of the Americas due to resistance [47]. Although the limit between periods at the turn of the century is arbitrary, it reflects distributional changes in the ranges of the two urban Aedes vectors as well as the increase of case reports in sizeable regions all over the world—being, for example, previous to any contemporary record of autochtonous Aedes-born disease transmission in Europe and Japan. The bases of the current globalization of international movements were established in the last decade of the 20th century (e.g., with the fall of the Iron Curtain, the advent of the Internet, and the start of low-cost flights); and their full potential was reached just after the start of the 21st century (e.g., with the opening of international borders, the widespread access to the Internet and to cell phones, and the online travel booking generalization). In fact, from 1970 to 2000, global exports nearly doubled to approximately a quarter of global GDP [48]. The time stratification also provides further opportunities for model validation. Thus, predictions afforded by the late 20th-century models were validated using early 21st-century datasets, and validations of the early 21st-century-model predictions were addressed with post-2017 records. In addition, by performing separate analyses for both centuries, we were able to integrate, in our 21st-century models, social and ecological descriptors that are only available for the last two decades.
Methodological framework
The ultimate objective of our analyses was to build a map that quantified the current level of dengue transmission risk worldwide. This map results from the combination of both a model describing favorable areas for the presence of vectors, and a model describing favorable areas for the occurrence of disease cases. These models were based on the predictive power of macro-environmental and spatial variables that included climate, topo-hydrography, vegetation, human activity, spatial autocorrelation, and potential for enzootic transmission. We first produced models focused on the late 20th century, which were later updated for the early 21st century through a procedure that involved reparameterization and the addition of variables representing changes in the distribution of the modelled item (i.e., of vector presences and dengue cases). The rationale for this addition is that, when animal and pathogen species spread, their distribution at a given moment is influenced by (1) the inertia of previous situations (i.e., temporal autocorrelation), here represented by the late 20th-century model, and (2) by a multifactorial set of new drivers potentially favoring the spread (i.e., spatial autocorrelation, environmental and socio-economic factors). A schematic description of our methodological framework is represented in Fig 1. The outputs of these models were expressed as favorability values (F, ranging 0–1) that represent the degree to which environmental conditions, at a particular spatial unit, favor the occurrence of a given event. Thus, favorability is equivalent to a degree of membership in the fuzzy set of environmentally favorable units [49], so that models based on favorability can be compared and combined through the implementation of fuzzy-sets theory tools [50]. F was calculated according to the Favorability Function [49, 51], defined by the following formula:
where P is the probability of occurrence of the event in question, n1 is the number of recorded occurrences, and n0 is the number of units in which occurrences have not been recorded. P values were calculated through forward-backward stepwise logistic regression (using IBM SPSS Statistics 23), in which predictor variables were selected according to Rao’s score tests [52], and derived from the formula:
where e is the basis of Napierian logarithms, and y is the “logit equation”, i.e. a linear combination of the predictor variables selected. We used iterative log-likelihood maximization for y-coefficient parameterization using a gradient ascent machine learning algorithm, and Wald tests [53] for evaluating the contribution of every variable in a model. The forward-backward stepwise approach prevents redundancy between variables in a model, as variable removal along the stepwise variable selection is allowed. Nevertheless, we strengthened prevention against excessive multicollinearity by preventing variables with Spearman correlation coefficients >0.8 from coinciding in the same model [18]. In case this happened, the least significant variable was deleted and the model was trained again. Benjamini and Hochberg’s [54] procedure for calculating the False Discovery Rate (FDR) was followed to minimise Type I errors that could occur from the consideration of a large number of variables.
Vector models
We built a global database of dengue vectors on the grid of 7,774-km2 hexagonal units, through the projection of georeferenced records into hexagons, using ArcGIS 10.3. Records on mosquito species involved in the urban cycle, i.e., Ae. aegypti and Ae. albopictus, for the period 1970–2014, were taken from “The global compendium of Aedes aegypti and Ae. albopictus occurrence” [55] (S1 Table). Later occurrences were retrieved from the expert-validated citizen-science platform Mosquito Alert (http://www.mosquitoalert.com/) and from VectorBase (https://www.vectorbase.org/).
Available records on sylvatic vectors [28, 56–58] (mosquito species Ae. polynesiensis, Ae. luteocephalus, Ae. africanus, Ae. niveus and Ae. vittatus) were obtained from the literature (S2 Table), Vectormap (vectormap.si.edu), and Gbif (https://gbif.org) (S1 Table).
A worldwide favorability model was built for each mosquito species, using presence/absence of occurrence records at each hexagon as dependent variables, and environmental (i.e., climate, topo-hydrography, vegetation, and human-activity) descriptors as independent predictor variables (S3 Table). Only variables that can be considered reasonably stable in the short term were used at this stage of the analysis, due to the scarcity of high-resolution data for the late 20th century and the changing nature of environments during the study period. Thus, climate was represented by average values for the period 1979–2013 [59], vegetation was described using terrestrial ecoregions [60], and the human factor was represented by the distance to populated settlements [61] (thus avoiding having to change parameters such as population density, land use, and infrastructure). In addition to environmental variables, we used a trend surface approach [62] to account for purely spatial factors linked to contagious evolutionary and ecological processes preventing or promoting distribution shifts [62, 63]. The spatial factor could distinguish areas with similar environmental conditions but different probabilities of being reached by a spreading species. This could happen because of spatial autocorrelation (i.e., the species could have nearby populations in some cases); or it could be a result of recent introductions or reintroductions. On every continent that the species occur, we developed a favorability model based on purely spatial descriptors [45] (i.e., 1st to 3rd-degree polynomial combinations of latitude and longitude). Then we added the resulting spatial-model outputs to the set of environmental variables.
In the case of urban-cycle mosquitoes, we generated favorability models based on late 20th-century occurrence records, subsequently updated for the early 21st century. We updated it by developing a model based on early 21st-century occurrence records. This model was completed in two blocks: (1) forcing the entry, as predictor variable, of the late 20th-century-model logit equation; and (2) performing a later stepwise selection in which only variables with the potential to account for changes with respect to the late 20th-century model were selected. This two-block variable selection was implemented using IBM SPSS Statistics 23.
Models for sylvatic-cycle mosquito species were run without temporal considerations, using the above-mentioned set of predictor variables. This is justified by the scarcity of occurrence records available for these species and by the assumption that their ranges have not changed substantially during the study period, which is based on a comparison of descriptions in the historical literature [58, 64, 65].
A vector favorability model for the late 20th century was produced using a combination of all individual vector models, including those for the sylvatic vectors and those for the urban vectors. We used the fuzzy union [66] for this purpose, which consisted of selecting, for every hexagon, the highest favorability value among those obtained in an individual model. The rationale for this criterion was that, if the pathogen is present in the area, the mere presence of one vector species already implies some potential for disease transmission to humans. Similarly, we created a vector model for the early 21st century.
Disease model
The global record of dengue cases was projected onto 7,774-km2 hexagons using ArcGIS 10.3. Georeferenced cases for the period 1970–2017 were obtained from the Messina et al.’s database [9], and considered only if they matched with the following criteria: (1) they were referred to precise locations, or (2) they were referred to centroids of polygons whose extensions were lower than or similar to the size of the hexagons (S1 Table). These data were completed with reports from Promedmail.org, using "DENGUE" as the keyword and limiting the search to the period 2013–2019, and with data provided by the epidemiological bulletins and weekly epidemiological surveillance of the Ministries of Health from Brazil, Costa Rica, Colombia, Ecuador, United States of America, Philippines, Honduras, Malaysia, Mexico, Myanmar, Palau, Puerto Rico, Samoa, Sri Lanka, and Thailand. In addition, we carried out searches in reports published by the European Centre for Disease Prevention and Control (ECDC): Communicable disease threats to public health in the European Union—Annual Epidemiological Report; and by the WHO: Dengue Situation Updates. Case reports for Africa were complemented with the Weekly Bulletin on Outbreaks and Other Emergencies (WHO, African Region), and publications available since 2017. Further information was obtained from the WHO and the Pan American Health Organization (PAHO) websites, and from the Global Infectious Disease and Epidemiology Online Network (GIDEON) [67].
We built a worldwide disease favorability model using presence/absence of case records at each hexagon as the dependent variable, and spatial/environmental descriptors as independent predictor variables (S3 Table). We used a similar methodological procedure as for vector species, including the performance of a late 20th-century model and its later update based on the early 21st century. The only difference with respect to the vector models was the inclusion of zoogeographical information in the set of predictor variables. This information defined the types of distribution ranges (i.e., chorotypes) of non-human primates, i.e., the most probable dengue reservoirs in the sylvatic cycles. A chorotype is a particular distribution pattern shared by a group of species, and may result from ecological and/or historical causes [68]. When knowledge of the reservoir-species complex is imprecise, the consideration of variables defining chorotypes shared by potential reservoirs helps to improve risk models referred to the distribution of zoonotic disease transmission [18, 23]. These primate-chorotype variables were defined in six steps:
Range maps of the African, Asian, and American primate species were obtained from the the IUCN [69], and were projected onto the grid of 7,774-km2 hexagons to produce a presence/absence matrix. The surface area of these units approximates the resolution below which extent-of-occurrence maps provided by the International Union for Conservation of Nature (IUCN) should not be employed for the characterization of macroecological patterns [70].
Chorotype analyses for each continent were addressed separately.
Primate ranges were classified hierarchically according to the Baroni-Urbani & Buser’s similarity index [71], using the unweighted pair-group method using arithmetic averages (UPGMA) [72, 73].
All clusters in the resulting classification dendrogram were assessed for statistical significance using the method proposed by Olivero and colleagues [19], which uses RMacoqui 1.0 software (http://rmacoqui.r-forge.r-project.org/). Groups of distributions that were significantly clustered were considered chorotypes.
For each chorotype, a predictor variable was defined using the chorotype species richness [19]; that is, in each hexagon, we quantified the number of species whose distributions formed part of the chorotype.
We then ran a forward-backward stepwise logistic regression using presence/absence of dengue case records as the dependent variable and chorotype variables as predictors. Only the chorotype-variables selected were considered henceforth.
We did not consider primates to be a limiting factor, since dengue cases among humans could be influenced by, but not depend on the presence of primates in the area [28]. Guided by this rationale, we produced the disease favorability model for the late 20th-century cases in two blocks: (1) a stepwise selection of environmental and spatial variables; (2) a later stepwise selection of chorotypes that contribute to improve significantly the model likelihood. In turn, the updating of the model based on cases from the early 21st century consisted of three blocks: (1) forcing the entry of the late 20th-century-model logit equation as a predictor variable; (2) making a later stepwise selection of spatial/environmental variables; (3) ending with a stepwise selection of chorotypes contributing to improve model likelihood.
Dengue transmission-risk model
We defined a dengue transmission-risk model according to the intersection between a disease model and a vector model. The fuzzy intersection is used to combine models that represent favorable conditions according to limiting factors (i.e., factors that describe imperative conditions for the modelled item to be present) [74]. Thus, the transmission-risk model reflected that, for the pathogen to be transmitted in a given hexagon, two elements must coexist: (1) suitable environmental conditions for disease cases to occur; and (2) suitable conditions for the presence of vectors. In operative terms, the intersection consisted of selecting, for every hexagon, the lowest favorability value among those obtained in the different models [66]. This approach has been used before to reflect the simultaneous need of suitable environments and mammal assemblages for the zoonotic transmission of the Ebola virus to humans [18]. Transmission-risk models were made for both the late 20th and the early 21st centuries. Favorability (F) values were finally reinterpreted as transmission-risk values following this scale: high favorability (i.e., F > 0.8 [75]) was referred as high transmission risk; intermediate-high favorability values (0.5 ≤ F ≤ 0.8) were referred as intermediate-high risk; intermediate-low favorability values (0.2 ≤ F < 0.5) were referred as intermediate-low risk; and low favorability (i.e. F < 0.2 [75]) was referred as low transmission risk. F = 0.2 and F = 0.8 match approximately the inflection points in the logistic favorability function, while F = 0.5 is the threshold above with the transmission probability defined by spatial and environmental factors is higher than the random transmission probability [51].
Transmission-model refinement
The early 21st-century dengue transmission-risk model was refined through model enhancing and downscaling. The models for the 21st century described above, based on variables that are also available for the late 20th century, were useful for risk-map comparisons between periods; however, an enhanced early 21st-century model permitted a more updated representation of factors that could aid in defining the risk of disease transmission. Enhancing was performed through the development of new disease and vector models on the basis of an expanded set of predictors, i.e. complementing the former set of variables with others only available for the early 21st century: human population density, infrastructures, land use, vegetation cover, and forest loss (S3 Table). Descriptors of livestock density were also considered for the enhancement of vector models. The proximity of human populations and activities not only imply the availability of human potential hosts. Human-modified environments usually provide chances for the local reproduction of urban Aedes mosquitoes (e.g. water points) [76].
The enhanced transmission-risk model was finally downscaled from the initial 7,774-km2 spatial resolution to a new grid based on 58,612 hexagons of 2,591 km2 (i.e. to 66.7% smaller units), using the direct downscaling approach [77]. Model predictions should remain meaningful after this downscaling has taken place as, according to Bombi & D’Amen [77], predictions are not severely affected by a 10-fold shortening of side lengths in the case of squared spatial units, which is equivalent to a 99% decrease of the surface area. The direct downscaling consisted of projecting the favorability equation that defined the original model to a set of variables considered in the finer-resolution grid of hexagons. In order to avoid local artifacts that could result from this downscaling, we excluded from the downscalled outputs all favorable areas that were not highlighted by the pre-downscaling models.
Model assessment and validation
Model goodness-of-fit was evaluated according to Chi-square tests. Discrimination capacity was assessed according to the area under the “receiver operating characteristic (ROC)” curve (AUC) [78]. We also assessed classification capacity based on two favorability thresholds: 0.5, at which probability is equal to the overall prevalence [51]; and 0.2, below which the risk of disease transmission was considered to be low (see above). The classification indices employed were the sensitivity, the specificity, the correct classification rate (CCR), Cohen’s kappa, the under-prediction rate, and the over-prediction rate [50, 79].
We validated the predictive capacity of the late 20th-century disease and transmission-risk models through the evaluation of their discrimination and classification capacities with regard to the 2001–2017 case record. Similarly, the predictive capacity of the early 21st-century model was validated with regard to the dengue cases reported in 2018 and 2019.
Contribution of the zoonotic factor
We used a variation partitioning approach [80] to calculate the relative contribution of non-human primates in determining the environmental favorability for the occurrence of dengue cases. We estimated how much of the variation in favorability for the occurrence of dengue cases was explained by the pure effect of primates (here represented by primate chorotypes), and how much was explained by the pure effect of environmental and spatial constraints. The method used [81] also allowed us to calculate how much of the variation in favorability was attributable to both factors (i.e., the shared effect), because primate ranges, in the same way as disease cases, are likely to be influenced by environmental and spatial constraints.
To map the areas in which the sylvatic cycle could have contributed to increase the record of dengue cases in humans, we identified the hexagons in which: 1) favorability values for the presence of dengue cases were ≥0.2; and 2) the difference between favorability values provided by the dengue model, and favorability values provided by a model not considering chorotypes, was positive and ≥0.1.
Results
Vector models
Urban mosquitoes
The global distribution of occurrence records and of favorable areas (as defined by environmental and spatial variables) (F≥0.2) for the presence of Ae. aegypti and Ae. albopictus in the late 20th and the early 21st centuries can be seen in S1 Fig. Ae. albopictus was less widespread but showed a more expansive spatial trend. In the late 20th century, favorable areas for Ae. aegypti covered extensive regions in North and South America, but included little of the inner Amazon basin. In contrast, Ae. albopictus exhibited highly restricted favorable areas in western USA and in South-Brazil coastal areas. In Africa, Ae. aegypti occupied large tropical regions, whereas Ae. albopictus only occurred in some areas to the south and the north-west of the continent and in Madagascar. Favorable areas for both species were similar in Asia, although they extended further westward for Ae. aegypti and eastward for Ae. albopictus. There were more favorable areas for Ae. aegypti in Australia than for Ae. albopictus, but the opposite was the case in New Zealand. In Europe, only Ae. albopictus occurred, with favorable areas extending across the Mediterranean region. These models are strongly characterized by the spatial factor, and highlight the environmental relevance of shorter distances to population centers and high annual precipitation (S4 and S5 Tables). The presence of Ae. aegypti was also favored by high summer temperatures though Ae. albopictus was favored in the temperate-conifer-forest ecoregion by low elevations and a high temperature annual range.
During the early 21st century (S1 Fig), favorable areas for Ae. aegypti in America reached most of the Amazon basin and expanded south to Argentina and Chile, as well as into North-West USA. Ae. albopictus occupied new areas in North and South America, and spread radially in Central Africa, northward into East Asia, and east and westward in the Mediterranean region of Europe. The models show that both species expanded their spatial/environmentally favorable areas into tropical broadleaf forests and temperate grasslands/savannas (S4 and S5 Tables). The range of Ae. aegypti also expanded in temperate conifer forests, and was favored by high winter temperatures. Ae. albopictus spread in the Mediterranean and in the temperate-broadleaf ecoregions, its presence favored by a high precipitation seasonality. For both species, the refined models outlined the relevance of human presence in explaining the ongoing spread: high human population density, intensive livestock rearing, and, for Ae. albopictus, the proximity of railways and roads.
Sylvatic mosquitoes
Details of the favorability models generated for the five sylvatic mosquito species are shown in S2 Fig and S6 and S7 Tables. The presence of the four continental species, namely Ae. africanus, Ae. luteocephalus, Ae. niveus, and Ae. vittatus, is favored by high minimum temperatures in the coldest months, and in some cases also by high maximum annual temperatures or high precipitation seasonality. Aedes polynesiensis was only characterized by its Pacific-insular spatial pattern. Some tropical ecoregions, linked to moist broadleaf forests or to grasslands and savannas, favor the presence of the African and Asian endemics. In contrast, the old-world species Ae. vittatus finds suitable habitats in Mediterranean landscapes as well, especially close to human-populated regions. The refined models highlight the relevance of humanized environments including the presence of croplands, areas inhabited by livestock or humans, and human infrastructures.
Integrated vector models
Favorable areas for the presence of at least one dengue-vector species, as outlined by the fuzzy union of all the single-species outputs, suggest key differences across the two centuries in South America, where spatial/environmentally favorable areas have spread, and in Australia, where favorability values have decreased (Fig 2). In the Mediterranean basin, favorable areas have extended to the Maghreb, and are beginning to spread to the European side.
Disease models
The distribution of favorable areas (F ≥ 0.2) for the presence of dengue cases shows that changes have taken place in the continents since the late 20th century (Fig 2). Favorable areas for dengue have spread southward in South America, inland in the Amazon, eastward in Africa, and to the south-west in Asia. Favorability values have also increased in South-East Asia, North Australia, and Papua New Guinea. The refined model also outlined favorable areas in Japan and South Korea (Figs 3 and S3). Europe, a dengue-free continent in the late 20th century, is currently showing favorable areas in the south, among which are a rising number of urban locations.
The proximity to population centers was the most significant predictor in the model that described areas favorable to the occurrence of dengue cases during the late 20th century (S8 Table). Dengue was favored in a variety of tropical ecoregions including forests and savannas, mangroves, montane grasslands, and xeric lands, as well as by low elevations and a high minimum temperature in the coldest month (S8 Table). Increasing favorability during the early 21st century occurred outside the tropical regions in temperate grasslands, and in areas with high maximum annual temperatures and high pluviometric irregularity but low annual temperature ranges and rainfall. As for the vectors, the refined disease model reaffirms the relevance of human presence. Primate chorotypes contributed significantly to all these models (see below).
Dengue transmission-risk models
Differences between the late 20th-century disease and transmission-risk models are most visible in South America (Fig 2A), where a vast area along the north-western coasts, and around rivers crossing the Amazon basin, were favorable for the presence of dengue and unfavorable for the presence of vectors. This was also the case in the Horn of Africa and in the north of Papua New Guinea. In contrast, in the early 21st century, this pattern was only seen in Peru, Bolivia, and Argentina, as well as in Saudi Arabia and Iraq (Fig 2B). The refined transmission-risk model for the early 21st century (Fig 3) still indicated significant risk areas in Japan, South Korea, and some European cities.
Model assessment
Model evaluation
The AUC values of all vector, disease, and transmission-risk models were >0.925 (Table 1), pointing to “outstanding” discrimination capacities according to Hosmer and Lemeshow [82], although this could be a result of the worldwide geographic extent of the calibration area. For a favorability threshold of 0.5, the CCR ranged between 0.771 and 0.884. Kappa values ranged between 0.228 and 0.252 in all the 20th-century models, and ranged between 0.352 and 0.544 in the early 21st-century models. Nevertheless, in the disease models and transmission-risk models for the 21st century, Kappa was always ≥0.518.
Table 1. Model assessment based on discrimination and classification capacities respect to vector and disease records of the same period.
MODEL | AUC | FCT | Kappa | Sens. | Spec. | CCR | Underp. | Overp. | |
---|---|---|---|---|---|---|---|---|---|
Late 20th century | Vector | 0.935 | 0.5 | 0.228 | 0.936 | 0.762 | 0.771 | 0.005 | 0.825 |
0.2 | 0.150 | 0.990 | 0.637 | 0.655 | 0.001 | 0.872 | |||
Disease | 0.934 | 0.5 | 0.234 | 0.893 | 0.851 | 0.852 | 0.004 | 0.838 | |
0.2 | 0.164 | 0.964 | 0.767 | 0.773 | 0.001 | 0.882 | |||
Transmission risk | 0.927 | 0.5 | 0.252 | 0.822 | 0.876 | 0.874 | 0.007 | 0.823 | |
0.2 | 0.178 | 0.926 | 0.794 | 0.798 | 0.003 | 0.873 | |||
Early 21st century | Vector | 0.926 | 0.5 | 0.352 | 0.925 | 0.760 | 0.777 | 0.011 | 0.704 |
0.2 | 0.210 | 0.991 | 0.580 | 0.620 | 0.002 | 0.795 | |||
Disease | 0.948 | 0.5 | 0.518 | 0.903 | 0.859 | 0.864 | 0.013 | 0.564 | |
0.2 | 0.359 | 0.980 | 0.730 | 0.757 | 0.003 | 0.696 | |||
Transmission risk | 0.939 | 0.5 | 0.533 | 0.822 | 0.888 | 0.881 | 0.024 | 0.531 | |
0.2 | 0.375 | 0.965 | 0.749 | 0.772 | 0.006 | 0.684 | |||
Early 21st century (refined) | Vector | 0.935 | 0.5 | 0.369 | 0.942 | 0.768 | 0.785 | 0.008 | 0.693 |
0.2 | 0.241 | 0.991 | 0.622 | 0.658 | 0.002 | 0.778 | |||
Disease | 0.956 | 0.5 | 0.531 | 0.903 | 0.866 | 0.870 | 0.013 | 0.552 | |
0.2 | 0.386 | 0.981 | 0.752 | 0.777 | 0.003 | 0.678 | |||
Transmission risk | 0.944 | 0.5 | 0.544 | 0.830 | 0.891 | 0.884 | 0.022 | 0.522 | |
0.2 | 0.418 | 0.955 | 0.784 | 0.803 | 0.007 | 0.652 |
The likelihood of underestimating the degree of favorability in areas where vectors and dengue cases occurred was low, as denoted by sensitivity values >0.800 (i.e., >80% of recorded presences were classified in favorable areas), and by under-prediction values <0.025 (i.e., less than 2.5% of the unfavorable spatial units showed recorded presences).
Compared to the 0.5-favorability threshold, when a 0.2 threshold was adopted, the CCR values of all models decreased by an average 12.67% (SD = 3.85), and kappa values decreased by an average 31.04% (SD = 4.90), which is related to the average 14.91% (SD = 4.25) decrease observed in the specificity values (i.e., some areas without presence records were shown by the models to increase in favorability). Nevertheless, the 0.2-threshold also minimized the likelihood of underestimating the degree of favorability in areas where vectors and dengue cases have occurred, as it produced an approximately 10% increase of the sensitivity values, and an approximately 75% decrease of the under-prediction values.
Predictive capacity
The late 20th-century disease and transmission-risk models demonstrated meaningful predictive capacities with respect to the early 21st-century dengue-case records. In many aspects, the assessments provided better results when the observations compared to the models were “future” cases than when we used for comparison the sets of records employed for model training (see Tables 1 and 2, and S9). The AUC values were always >0.910. Considering both the 0.5 and the 0.2-favorability thresholds, and compared to the above model evaluation, the kappa values of the disease and transmission-risk models increased by an average of 59.4% (SD = 5.1) when assessed with respect to all dengue cases reported during 1970–2017, which is similar to the 57.6% increase (SD = 5.1) when assessed with respect to the 2001–2017 cases alone. The CCR also experienced an average 4.6% increase (SD = 1.8) with respect to its evaluation values. This improvement was related to an average 5.8% increase (SD = 0.8) in model specificity, which was always >0.900 with the 0.5 favorability threshold (Table 2) and >0.820 with the 0.2 threshold. Sensitivity values experienced an average 14.3% decrease (SD = 4.9). Nevertheless, sensitivity was always >0.670 with the 0.5 threshold and >0.820 with the 0.2 threshold. Finally, the underprediction rate decreased by an average of 56.5% (SD = 13.8), which indicates that many favorable areas free from disease during the late 20th century experienced outbreaks after 2000.
Table 2. Validation of model predictive capacity based on discrimination and classification performance respect to disease records of a later period.
MODEL | Records of reference for validation purposes | AUC | FTC | Kappa | Sens. | Spec. | CCR | Underp. | Overp. | |
---|---|---|---|---|---|---|---|---|---|---|
Late 20th century | Disease | 1970 to 2017 | 0.925 | 0.5 | 0.558 | 0.778 | 0.905 | 0.891 | 0.031 | 0.486 |
0.2 | 0.463 | 0.888 | 0.826 | 0.833 | 0.017 | 0.604 | ||||
Transmission risk | 0.915 | 0.5 | 0.535 | 0.677 | 0.923 | 0.895 | 0.043 | 0.470 | ||
0.2 | 0.465 | 0.821 | 0.848 | 0.845 | 0.026 | 0.590 | ||||
Disease | 2001 to 2017 | 0.923 | 0.5 | 0.538 | 0.781 | 0.901 | 0.888 | 0.028 | 0.514 | |
0.2 | 0.440 | 0.888 | 0.820 | 0.827 | 0.016 | 0.627 | ||||
Transmission risk | 0.914 | 0.5 | 0.515 | 0.678 | 0.918 | 0.892 | 0.040 | 0.501 | ||
0.2 | 0.445 | 0.823 | 0.843 | 0.841 | 0.025 | 0.614 | ||||
Early 21st century | Disease | 2001 to 2019 | 0.948 | 0.5 | 0.548 | 0.898 | 0.867 | 0.870 | 0.015 | 0.530 |
0.2 | 0.385 | 0.979 | 0.737 | 0.765 | 0.004 | 0.671 | ||||
Transmission risk | 0.939 | 0.5 | 0.557 | 0.813 | 0.894 | 0.884 | 0.027 | 0.498 | ||
0.2 | 0.402 | 0.962 | 0.756 | 0.780 | 0.007 | 0.658 | ||||
Disease | 2018 and 2019 | 0.934 | 0.5 | 0.296 | 0.931 | 0.817 | 0.823 | 0.005 | 0.780 | |
0.2 | 0.186 | 0.987 | 0.689 | 0.705 | 0.001 | 0.850 | ||||
Transmission risk | 0.915 | 0.5 | 0.305 | 0.831 | 0.847 | 0.846 | 0.011 | 0.768 | ||
0.2 | 0.198 | 0.978 | 0.708 | 0.722 | 0.002 | 0.843 | ||||
Early 21st century (refined) | Disease | 2001 to 2019 | 0.957 | 0.5 | 0.561 | 0.898 | 0.873 | 0.876 | 0.015 | 0.517 |
0.2 | 0.414 | 0.979 | 0.759 | 0.785 | 0.004 | 0.651 | ||||
Transmission risk | 0.944 | 0.5 | 0.564 | 0.816 | 0.896 | 0.887 | 0.026 | 0.491 | ||
0.2 | 0.445 | 0.95 | 0.791 | 0.810 | 0.008 | 0.625 | ||||
Disease | 2018 and 2019 | 0.945 | 0.5 | 0.31 | 0.943 | 0.824 | 0.830 | 0.004 | 0.771 | |
0.2 | 0.202 | 0.989 | 0.710 | 0.725 | 0.001 | 0.841 | ||||
Transmission risk | 0.924 | 0.5 | 0.31 | 0.834 | 0.849 | 0.848 | 0.011 | 0.765 | ||
0.2 | 0.224 | 0.969 | 0.742 | 0.754 | 0.002 | 0.827 |
The early 21st-century (2001–2017) models also showed meaningful predictive capacities (Table 2). Compared to the above model assessment (referenced to the 2001–2017 data), when the whole 2001–2019 period was considered, the kappa values increased by an average of 5.6% (SD = 1.2), and the CCR values increased by 0.8% (SD = 0.3) (Tables 1, 2 and S9). When only the 2018 and 2019 data were employed, both kappa and CCR values decreased, but they were always >0.290 and >0.820, respectively, with the 0.5-favorability threshold, and >0.180 and >0.700, respectively, with the 0.2 threshold (Table 2).
Contribution of the sylvatic cycle
A total of 51 chorotypes were detected: 24 chorotypes in Asia, 13 in Africa, and 14 in America (S5–S7 Figs). Thus the early 21st-century disease model is an update of the late 20th-century disease model (see Fig 1), as all chorotypes in the latter are also included in the former. Taking this into account, Asia contributed to the late 20th-century model with two chorotypes, including species in the following genera: Hylobates, Trachyphitecus, Nomascus, and Pygathrix in chorotype AS8; and Hylobates, Presbytis, Nycticebus, and Trachypithecus in chorotype AS15. Four additional Asian chorotypes were included in the 21st-century model, with the following species: Macaca in chorotype AS5; Hylobates, Presbytis, Symphalangus, and Nycticebus in chorotype AS7; Loris, Semnopithecus, and Macaca in chorotype AS9; and Carlito in chorotype AS19. The African chorotype AF2, with the genera Arctocebus, Cercopithecus, Colobus, Euoticus, Gorilla, Lophocebus, Mandrillus, Miophitecus, and Sciurocheirus, was included in the 20th-century model, whereas no additional African chorotype was included in the 21st-century model. South America contributed to the 20th-century model with three chorotypes, including species in the following genera: Alouatta, Sapajus, Brachyteles, Callithrix, Callicebus, and Leontophitecus in chorotype SA4; Aotus, Cebus, Ateles, and Saguinus in chorotype SA5; and Aotus, Saguinus, Oreonax, and Callicebus in chorotype SA14. An additional South-American chorotype, SA2, was included in the 21st-century model, with species of the genera Alouatta, Ateles, Callicebus, Chiropotes, and Mico (all the variables included in the disease models can be seen in S8 Table).
Primate chorotypes contributed to explain a maximum of 16.4% of the variation in favorability for the presence of dengue in the late 20th century (Fig 4A). However, only 0.2% of the variation can be exclusively attributed to these chorotypes. The remaining 16.2% of the variation was indistinguishably attributed to chorotypes and to spatial/environmental factors, as the distribution of primate ranges is also dependent on the environment. In the early 21st-century model, chorotypes contributed a maximum of 9.8% to explain the variation in favorability, although only 0.7% could be exclusively attributed to them (Fig 4B).
The distribution of areas in which there was a >0.1 favorability increase, as an exclusive effect of primates, is shown in Fig 4. In the late 20th century, these areas were located in Java (Indonesia), in some areas of Cambodia and Vietnam, in northern Colombia, and in southern Brazil (Fig 4A). In the early 21st century, the possible contribution of primate chorotypes expanded to Sumatra in Indonesia, and also involved Asian areas of Afghanistan, Pakistan, India, Nepal, and China in Asia, Amazonian areas of Brazil, and some African countries in the western Congo basin, mainly Cameroon, Gabon, Equatorial Guinea, and the Republic of Congo (Fig 4B).
Discussion
Our pathogeographic approach is the first to explicitly generate a high-resolution analysis of the geographic changes experienced in the dengue-transmission risk since the late 20th century. During the past century, dengue cases have been reported across a wide range of tropical ecoregions. Based on our research findings, we suggest that areas at risk of dengue transmission included regions in which cases only started being reported after 2000. We show that the distributions of Aedes aegypti and Ae. albopictus were principally linked to human presence in lowland tropical areas, although Ae. albopictus started to occur in some temperate regions as well. In the current century, dengue-risk areas continue to spread, reflecting the fact that both Aedes species are expanding their ranges into a number of temperate ecoregions worldwide. Our study is useful as a basis for suggesting specific management strategies according to the spatial distribution of factors favoring risk, and is the first to take into account the potential contribution of primate biogeography and sylvatic vectors in increasing the risk of dengue transmission.
In certain areas in South Asia that were free from dengue two decades ago, such as Pakistan, the presence of dengue and the occurrence of vectors were environmentally favored; thus, we predict the risk of dengue transmission in those areas. The early 21st-century disease reports strongly confirm this forecast (Fig 5A). In contrast, in the Amazon basin, a successful forecast for the near future was provided by the disease model, but the same was not true of the transmission-risk model, which suggested that dengue presence, but not vector presence, was favored by the environment (Fig 5B). Hence, the Pakistani and Amazonian scenarios would require different prevention strategies. The risk in Pakistan was evident, so ensuring a close microbiological and epidemiological surveillance would have been reasonable (e.g., in the presence of clinically compatible cases, dengue should be suspected and microbiologically confirmed). In the Amazon, meanwhile, the arrival of invasive vectors should have been prevented, but now Ae. aegypti and Ae. albopictus occur near rivers and tributaries across the basin (Fig 5B). Predicting the establishment of invasive species in new areas is difficult. The dispersal of Aedes is strongly influenced by travel and trade routes [37, 39], as much as by the worldwide propagation of pathogens [39, 83]. The progressive spread of invasive Aedes species into temperate ecoregions could also be influenced by climate change [9, 84, 85]. However, this situation is further aggravated if anthropogenic factors affect their evolutionary and consequently adaptive potential [41].
The predictive power of our late 20th-century models can be assumed for the early 21st-century models as well, as all of them were derived from the same method. The predictive capacity of the 21st-century models has been confirmed by the reported occurrence of autochthonous dengue after 2017 in Muscat (Oman) [86], Kyoto, and Nara (Japan) [87], and in Spanish coastal cities [88, 89] (S3 Fig). The early 21st-century transmission-risk models predict a spread of the risk in still barely affected areas exposed to the presence of invasive Aedes. This is particularly relevant in South-East China, but also in Papua New Guinea, North Australia, South USA, the interior regions of Colombia and Venezuela, Madagascar, and, according to the refined model, also in Japan and urban areas of South and Central Europe. Our results suggest that dengue could spread into areas of Argentina and South-West Asia (from Pakistan to the Arabian Peninsula) where invasive Aedes species occur but are scarcely reported (see S8 Fig). In addition, populated areas in Chile, Iran, Iraq, and the Maghreb, still free from invasive Aedes, exhibit favorable conditions for the occurrence of vectors and disease. The imminent risk in these locations, despite their distance from the dengue-native regions, should not be discounted given the high level of global connectivity [39] and the influence of human-population density on the intensity of dengue transmission [13]. Relevant precedents are the current expansive trend of autochthonous dengue in the Mediterranean cities [89], and a local transmission reported in New York (USA) [90] that was predicted two years previously [91]. The northern coasts of Chile now have a similar situation to what has been seen in the Amazon basin over the past century; vectors have not yet arrived there but the area—which is environmentally similar to the dengue-affected coasts of Peru—is favorable to the presence of dengue cases. Management policies to prevent the arrival of invasive mosquitoes should be strongly encouraged. Finally, the eastern half of the USA and large sections of South-Saharan Africa exhibit unfavorable conditions (in spatial and/or environmental terms) for dengue even though these areas exhibit some limited favorable conditions and are home to Aedes mosquitoes. Thus, measures to be taken should depend on the socioeconomic and environmental conditions of the region. In eastern USA, international travellers should be educated about the threat of mosquito-borne diseases and on the importance of using repellents in endemic areas in order to prevent this region from becoming a spatially favorable zone for local transmission. In Africa, microbiological and epidemiological surveillance should be encouraged and, when needed, internationally supported.
Any distribution modelling approach is subject to limitations primarily derived (1) from the spatio-temporal dynamism of the modelled facts, (2) from uncertainties in the quality of the available information, and (3) from the interpretation of patterns based on correlations between dependent and independent variables (i.e., correlative approaches). First, a high spatio-temporal dynamism affects the distribution of dengue cases and Aedes mosquito species. Because of this, the transmission risk in areas that have been favorable for dengue in the past might not always be highlighted by our models. Chances for the disease to reach areas with similar environmental conditions might be different, conditioned by the geographical proximity of vectors and pathogens, i.e. because of the spatio-temporal autocorrelation. We took this autocorrelation into account by considering the spatial factor in the set of predictor variables. Consequently, these models were designed for specific contexts in the spatio-temporal dimension, and so they should be interpreted as focused on the current historical moment. Second, a low quality in the data set might have been a serious drawback in our models if the distribution of false absences were biased with respect to the gradient of environmental conditions, and also if the modelling method used were susceptible to overfitting. One of the methods we employed to addres this problem was the grid approach, as it reduced to a large extent the proportion of area considered to be free from dengue and vectors in the database. In addition, overfitting does not characterize our methodological approach [92], as was confirmed by the fact that 11–42% of the “absence” hexagons were predicted to be favorable by the models (see specificity in Table 1). In any case, some bias could occur in poorly sampled regions, for example in Africa [93], where model predictions should be interpreted with caution. Finally, a cautiounary approach is always advised when using correlative methods. Measures can be taken to avoid multicollinearity and type I errors, but the link between observed covariances and cause-effect relations always depends on the robustness of the a-priori hypotheses supporting the predictors data set. We were careful in this respect, but we still found a little artifact derived from the model downscaling to smaller hexagons. This procedure led us to estimate a high risk of dengue transmission in some populated cities that are geographically distant from the areas highlighted by the pre-downscaling model. We corrected this artifact, so that the final output ensured a total correspondence between models before and after the downscaling procedure (see Figs 3 and S4).
Our model for defining areas at risk of dengue transmission is broadly similar to those produced in previous studies. However, some differences are worth highlighting. We focus on Messina et al.’s research in 2019 [9], as it provides an update of previous maps [5, 94] and, as we do here, takes into account the distribution of suitable areas for vectors. There are three main methodological differences that could explain discrepancies between our outputs and previous maps: (1) the treatment given to the temporal dimension, (2) the assumptions made for including vector distributions in the models, and (3) the application of a different modelling method (i.e., the logistic regressions and the Favorability Function).
Our models provide perceptions of current trends such as the spread of dengue in the Amazon basin and southern Asia, resulting from the temporal stratification. In addition, our models were trained with cases reported up to 2017, whereas Messina et al. [9] only considered cases up to 2015 and excluded the autochthonous cases that occurred in Europe. This could explain the differences for Europe, Argentina, and Uruguay. We suggest the presence of a high transmission risk in southern France and northern Italy. In South America, as predicted by our models, recent reports demonstrate a significant risk in central Argentina, Peru, Bolivia, Paraguay, and southern and North-West Uruguay (PAHO in www.paho.org; ECDC in ecdc.europa.eu reports), where Messina et al.’s predictions only suggest a modest increase acros the century as a result of climate-warming projections.
The high risk suggested by Messina et al. [9] for the eastern half of the USA is a major difference with our transmission-risk map, as risks in that area depend only on the presence of Aedes mosquitoes (compare vector and disease models in Fig 3). The way vector species are integrated in a risk model reflects the a priori assumptions that are adopted with respect to these vectors’ role in the pathogen transmission. In the case of dengue, it depends entirely on mosquitoes, and so it seems reasonable to adopt an intersection approach in which the risk points to areas favorable to both pathogen and vectors. We did this, and Messina et al. also exclude all areas environmentally unsuitable for vectors from their map [9]. However, their model also considered vectors as part of the predictor-variable ensemble, and this allowed the environment and the vector presence to counter-balance each other with no limiting-factor concerns [74]. We believe that this is justified, because the mere presence of vectors is a risk factor [37, 95]. However, this fact is sufficiently highlighted by a vector model, and the ability to differentiate between factors favoring risk is conductive to evaluating urgency and designing prevention strategies, as seen above. Our approach highlights transmission risks in areas in which both the vector and the disease are environmentally favored, but we also suggest that, regardless of the existence of vector reports, the presence of favorable environments for infections to occur should sound a warning in the event of unprecedented autochthonous cases. These situations, such as that of the Amazon in the late 20th century, are only detected by disease models that are kept “blind” to the vector factor during its training phase.
Lastly, our models show particularities that could result from the performance of the algorithms employed. The most glaring case is related to risk predictions involving the entire Mexican territory, whereas these risks are limited to the coasts in previous models [9]. The trend of dengue cases reported in Mexico after 2000 suggests an inland-spread of favorable areas.
In Asia, Africa, and South America, the areas prone to risk of zoonotic transmission to humans—according to our models—largely overlap with dengue transmission-intensity hotspots [13]. Although human-to-human transmission in urban contexts represents the most important virus cycle from the epidemic point of view [26], zoonotic transmission from other primates has also occurred in tropical regions in Asia and Africa [28], suggesting that the medical relevance of forest cycles is, perhaps, underestimated. This means that active disease surveillance, such as that employed in Brazil for the yellow fever [96], could be misused. According to our results, sylvatic dengue cycles account for a small percentage of the global extent of the human case record, but could be meaningful in sanitary terms in some tropical areas.
The Asian areas with recorded transmissions of forest-dengue serotypes to humans are located in peninsular Malaysia [97, 98] and Borneo [99, 100]. Besides, positive serological responses to the dengue virus have been detected in non-human primates from Indonesia, the Philippines, Cambodia, Vietnam, Malaysia and Thailand [98, 101–103]. The maps presented here suggest that non-human-primate distributions may increase the environmental favorability for the presence of dengue cases in Indonesia (Java and Sumatra), Cambodia, and Vietnam (Fig 4). The fact that these areas overlap with those with seropositivity in non-human primates, and are only approximately 500 km away from locations of confirmed forest dengue in humans, endorses our outputs. Serological surveys and experiments point to the primate genera Presbytis and Macaca—which are widely represented in the chorotypes involved in our disease models (S5 Fig)—as dengue reservoirs and amplification hosts, suggesting that other areas in Asia could be undiscovered foci of zoonotic dengue transmission [28]. This could be the case for Pakistan, Afghanistan, northern India, Nepal, and China, all inhabited by the genus Macaca and here outlined as areas of zoonotic transmission risk (Fig 4B).
In Africa, human infections by a forest dengue serotype were detected in 1966 in Ibadan, Nigeria [56], approximately 1,000 km from the areas where sylvatic cycles could amplify the risk of dengue transmission according to our models: Cameroon, Equatorial Guinea, Gabon, Congo, and the Democratic Republic of the Congo (Fig 4). The Congo basin, specifically Gabon, could have recently experienced epizootic transmission in non-human primates [104]. The record of humans affected by sylvatic dengue also points to regions in western Africa such as Senegal [105, 106]; additionally, epizooties in primates could have also occurred in Nigeria [107], Senegal [108, 109], and Kenya [110]. Species belonging to the genera Chlorocebus, Erythrocebus, and Papio are considered to be dengue reservoirs or amplification hosts [28]. Species from these genera help to characterize the distribution of dengue cases in Africa, while close relatives from the same tribe (e.g., Miopithecus and Cercopithecus) inhabit the Congo-basin areas here suggested to be at risk of zoonotic dengue transmission (S6 Fig).
Forest occupancy by human activities is considered to be a driver of disease emergence [111–114], increasing the relevance of sylvatic dengue spillover in tropical regions [115]. In Asia and Africa, the real extent of transmission with an enzootic origin could have been neglected due to the impossibility of discerning between forest and urban serotypes [28]. However, spillback cases with primates acting as reservoirs for urban dengue serotypes could also occur [116], and this might be happening in South America [33, 34]. Seropositivity to the dengue virus has been documented in species from the genus Alouatta in north-eastern Argentina [117] and Costa Rica [118], from Cebus in Costa Rica [118], and from Leontopithecus in south-eastern Brazil [119]. Precisely, south-eastern Brazil, specifically the Atlantic forests surrounding Bahia, is highlighted by our model as an area at risk of zoonotic transmission to humans (Fig 4). In this region, the yellow-fever virus shows evolutionary dynamics linked to forest primates [32], and vectors of this virus have shown positivity to the presence of dengue strains [33]. Our model also points to a sylvatic-cycle influence on dengue-case occurrence in the Brazilian Amazon, involving chorotypes that include species of the primate genera Alouatta and Cebus (Figs 4 and S7).
In conclusion, the human influence on the dispersal of Aedes mosquitoes, as much as the adaptive potential of these animals, make environments currently supporting the presence of dengue vectors not represent the range of conditions that might allow them to establish populations. Our vector model predictions should, therefore, be taken seriously when detecting favorable areas for the presence of invasive Aedes, and should be considered to be conservative when neglecting the risk in areas that have already reported pioneer populations. Preventing the arrival of invasive mosquitoes is very important, specially in areas where environmental conditions favor transmission of dengue. If vectors already occur in the area, but virus transmission is not environmentally favored, prevention policies should focus on international-traveller education and microbiological surveillance. Our models are also conservative in mapping the increase of favorability derived from the sylvatic cycle, as we only mapped areas where the contribution of primate chorotypes was not correlated with environmental factors such as presence of tropical forests. Thus, the areas prone to sylvatic dengue transmission could be larger than estimated, mostly in Africa. The concentration of evidence suggest the need for studies that address the occurrence of dengue sylvatic cycles in the Atlantic forest of Brazil and the Amazon. Besides, we suggest that forests in north-western Colombia be investigated for sylvatic cycles, as a chorotype including a Cebus species seems to have contributed to the increased risk of dengue transmission in the recent past.
Supporting information
Acknowledgments
We thank Adrían Martín-Taboada for his contribution in the grid-cell design, and Jose M. García-Carrasco for his support with the verification of some predictor variables.
Data Availability
The data with the compendium of dengue cases from 2013 to 2017 that support the findings of this study are available in Dryad Digital Repository at https://doi.org/10.5061/dryad.9w0vt4bfv.
Funding Statement
This study was supported by the Project CGL2016-76747-R, of the Spanish Ministry of Economy, Industry and Competitiveness and the European Regional Development Fund. AA-S was supported by the FPU16/06710 grant of the Spanish Ministry of Education. JEF was funded by USAID as part of the Bushmeat Research Initiative of the CGIAR research program on Forests, Trees and Agroforestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 2002;10: 100–103. doi: 10.1016/s0966-842x(01)02288-0 [DOI] [PubMed] [Google Scholar]
- 2.World Health Organization. Dengue and severe dengue. In: WHO [Internet]. 2020. Available: https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
- 3.Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ, et al. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis. 2016;16: 712–723. doi: 10.1016/S1473-3099(16)00026-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.World Health Organization. Global strategy for dengue prevention and control 2012–2020. 2012. Available: https://www.who.int/denguecontrol/9789241504034/en/
- 5.Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496: 504–507. doi: 10.1038/nature12060 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Grange L, Simon-Loriere E, Sakuntabhai A, Gresh L, Paul R, Harris E. Epidemiological risk factors associated with high global frequency of inapparent dengue virus infections. Front Immunol. 2014;5: 1–10. doi: 10.3389/fimmu.2014.00001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop Med Int Heal. 2009;13: 1328–1340. doi: 10.1111/j.1365-3156.2008.02151.x.Clinical [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kuno G. A Re-Examination of the History of Etiologic Confusion between Dengue and Chikungunya. PLoS Negl Trop Dis. 2015;9: 1–11. doi: 10.1371/journal.pntd.0004101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Messina JP, Brady OJ, Golding N, Kraemer MUG, Wint GRW, Ray SE, et al. The current and future global distribution and population at risk of dengue. Nat Microbiol. 2019;4: 1508–1515. doi: 10.1038/s41564-019-0476-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Peterson AT. Ecologic niche modeling and spatial patterns of disease transmission. Emerg Infect Dis. 2006;12: 1822–1826. doi: 10.3201/eid1212.060373 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Purse BV, Golding N. Tracking the distribution and impacts of diseases with biological records and distribution modelling. Biol J Linn Soc. 2015;115: 664–677. doi: 10.1111/bij.12567 [DOI] [Google Scholar]
- 12.Hay SI, Battle KE, Pigott DM, Smith DL, Moyes CL, Bhatt S, et al. Global mapping of infectious disease. Philos Trans R Soc B Biol Sci. 2013;368: 20120250. doi: 10.1098/rstb.2012.0250 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Cattarino L, Rodriguez-Barraquer I, Imai N, Cummings DAT, Ferguson NM. Mapping global variation in dengue transmission intensity. Sci Transl Med. 2020;12. doi: 10.1126/scitranslmed.aax4144 [DOI] [PubMed] [Google Scholar]
- 14.Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, et al. Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus. PLoS Negl Trop Dis. 2012;6: e1760. doi: 10.1371/journal.pntd.0001760 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Messina JP, Brady OJ, Scott TW, Zou C, Pigott DM, Duda KA, et al. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 2014;22: 138–146. doi: 10.1016/j.tim.2013.12.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kraemer MUG, Reiner RC, Brady OJ, Messina JP, Gilbert M, Pigott DM, et al. Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat Microbiol. 2019;4: 854–863. doi: 10.1038/s41564-019-0376-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Pigott DM, Millear AI, Earl L, Morozoff C, Han BA, Shearer FM, et al. Updates to the zoonotic niche map of Ebola virus disease in Africa. Elife. 2016;5: e16412. doi: 10.7554/eLife.16412 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Olivero J, Fa JE, Real R, Farfán MÁ, Márquez AL, Vargas JM, et al. Mammalian biogeography and the Ebola virus in Africa. Mamm Rev. 2017;47: 24–37. doi: 10.1111/mam.12074 [DOI] [Google Scholar]
- 19.Olivero J, Real R, Márquez AL. Fuzzy chorotypes as a conceptual tool to improve insight into biogeographic patterns. Syst Biol. 2011;60: 645–660. doi: 10.1093/sysbio/syr026 [DOI] [PubMed] [Google Scholar]
- 20.Romero D, Olivero J, Real R, Guerrero JC. Applying fuzzy logic to assess the biogeographical risk of dengue in South America. Parasites and Vectors. 2019;12: 1–13. doi: 10.1186/s13071-018-3256-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Guernier V, Hochberg ME, Guégan JF. Ecology drives the worldwide distribution of human diseases. PLoS Biol. 2004;2: 740–746. doi: 10.1371/journal.pbio.0020141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Murray KA, Preston N, Allen T, Zambrana-Torrelio C, Hosseini PR, Daszak P. Global biogeography of human infectious diseases. Proc Natl Acad Sci U S A. 2015;112: 12746–12751. doi: 10.1073/pnas.1507442112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Murray KA, Olivero J, Roche B, Tiedt S, Guégan JF. Pathogeography: leveraging the biogeography of human infectious diseases for global health management. Ecography (Cop). 2018;41: 1411–1427. doi: 10.1111/ecog.03625 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wilson ML. Ecology and infectious disease, in Ecosystem Change and Public Health: A Global Perspective. Aron J.L.and Patz J.A., editor. Baltimore: Johns Hopkins University Press, Baltimore; 2001. [Google Scholar]
- 25.Rico-Hesse R. Molecular evolution and distribution of dengue viruses type 1 and 2 in nature. Virology. 1990;174: 479–493. doi: 10.1016/0042-6822(90)90102-w [DOI] [PubMed] [Google Scholar]
- 26.Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998;11: 480–496. doi: 10.1128/CMR.11.3.480 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Holmes EC, Twiddy SS. The origin, emergence and evolutionary genetics of dengue virus. Infect Genet Evol. 2003;3: 19–28. doi: 10.1016/s1567-1348(03)00004-2 [DOI] [PubMed] [Google Scholar]
- 28.Vasilakis N, Cardosa J, Hanley KA, Holmes EC, Weaver SC. Fever from the forest: Prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol. 2011;9: 532–541. doi: 10.1038/nrmicro2595 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Bryant J, Wang H, Cabezas C, Ramirez G, Watts D, Russell K, et al. Enzootic transmission of yellow fever virus in Peru. Emerg Infect Dis. 2003;9: 926–933. doi: 10.3201/eid0908.030075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Baronti C, Goitia NJV, Cook S, Roca Y, Revollo J, Flores JV, et al. Molecular epidemiology of yellow fever in Bolivia from 1999 to 2008. Vector-Borne Zoonotic Dis. 2011;11: 277–284. doi: 10.1089/vbz.2010.0017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Auguste AJ, Lemey P, Bergren NA, Giambalvo D, Moncada M, Morón D, et al. Enzootic transmission of yellow fever virus, Venezuela. Emerg Infect Dis. 2015;21: 99–102. doi: 10.3201/eid2101.140814 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Mir D, Delatorre E, Bonaldo M, Lourenço-De-Oliveira R, Vicente AC, Bello G. Phylodynamics of Yellow Fever Virus in the Americas: New insights into the origin of the 2017 Brazilian outbreak. Sci Rep. 2017;7: 1–9. doi: 10.1038/s41598-016-0028-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.de Figueiredo ML, De C Gomes A, Amarilla AA, de S Leandro A, de S Orrico A, de Araujo RF, et al. Mosquitoes infected with dengue viruses in Brazil. Virol J. 2010;7: 152. doi: 10.1186/1743-422X-7-152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Roberts DR, Peyton EL, Pinheiro FP, Balderrama F, Vargas R. Associations of arbovirus vectors with gallery forests and domestic environments in southeastern Bolivia. Bull Pan Am Health Organ. 1984;18: 337–350. [PubMed] [Google Scholar]
- 35.de Thoisy B, Lacoste V, Germain A, Muñoz-Jordán J, Colón C, Mauffrey JF, et al. Dengue infection in neotropical forest mammals. Vector-Borne Zoonotic Dis. 2009;9: 157–169. doi: 10.1089/vbz.2007.0280 [DOI] [PubMed] [Google Scholar]
- 36.Marcondes CB, Tauil PL. Dengue silvestre: Devemos nos preocupar? Rev Soc Bras Med Trop. 2011;44: 263–264. doi: 10.1590/s0037-86822011000200029 [DOI] [PubMed] [Google Scholar]
- 37.Tatem AJ, Hay SI, Rogers DJ. Global traffic and disease vector dispersal. Proc Natl Acad Sci U S A. 2006;103: 6242–6247. doi: 10.1073/pnas.0508391103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Leta S, Beyene TJ, De Clercq EM, Amenu K, Kraemer MUG, Revie CW. Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus. Int J Infect Dis. 2018;67: 25–35. doi: 10.1016/j.ijid.2017.11.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Kraemer MUG, Sinka ME, Duda KA, Mylne AQN, Shearer FM, Barker CM, et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife. 2015;4: e08347. doi: 10.7554/eLife.08347 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gossner CM, Ducheyne E, Schaffner F. Increased risk for autochthonous vector-borne infections transmitted by Aedes albopictus in continental europe. Eurosurveillance. 2018;23: 2–7. doi: 10.2807/1560-7917.ES.2018.23.24.1800268 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Brown JE, Evans BR, Zheng W, Obas V, Barrera-Martinez L, Egizi A, et al. Human impacts have shaped historical and recent evolution in Aedes aegypti, the dengue and yellow fever mosquito. Evolution (N Y). 2014;68: 514–525. doi: 10.1111/evo.12281 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Gibbs EPJ. The evolution of One Health: a decade of progress and challenges for the future. Vet Rec. 2004;174: 85–91. doi: 10.1136/vr.g143 [DOI] [PubMed] [Google Scholar]
- 43.Gething PW, Van Boeckel TP, Smith DL, Guerra CA, Patil AP, Snow RW, et al. Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax. Parasites and Vectors. 2011;4: 1–11. doi: 10.1186/1756-3305-4-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Barnes R. dggridR: Discrete Global Grids for R. R package version 2.0.4. Zenodo. 2017. doi: 10.5281/zenodo.1322866 [DOI]
- 45.Legendre P, Legendre L. Numerical ecology (2nd English edition). Amsterdam, The Netherlands: Elsevier Science; 1998. [Google Scholar]
- 46.Soper FL. The elimination of urban yellow fever in the Americas through the eradication of Aedes aegypti. Am J Public Health. 1963;53: 7–16. doi: 10.2105/ajph.53.1.7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Maestre-Serrano R, Rey G, De las salas J, Vergara C, Santacoloma L, Goenaga S, et al. Estado de la susceptibilidad de Aedes aegypti a insecticidas en Atlántico (Colombia). Rev Colomb Entomol. 2010;36: 242–248. [Google Scholar]
- 48.Mometrix Test Preparation. Millennium Milestones of Globalization. 2021. Available: https://www.mometrix.com/academy/globalization-millennium-milestones/
- 49.Real R, Barbosa AM, Vargas JM. Obtaining environmental favourability functions from logistic regression. Environ Ecol Stat. 2006;13: 237–245. doi: 10.1007/s10651-005-0003-3 [DOI] [Google Scholar]
- 50.Barbosa AM, Real R. Applying fuzzy logic to comparative distribution modelling: a case study with two sympatric amphibians. Sci World J. 2012;2012: 1–10. doi: 10.1100/2012/428206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Acevedo P, Real R. Favourability: Concept, distinctive characteristics and potential usefulness. Naturwissenschaften. 2012;99: 515–522. doi: 10.1007/s00114-012-0926-0 [DOI] [PubMed] [Google Scholar]
- 52.Radhakrishna Rao C. Large sample tests of statistical hypotheses concerning several parameters with applications to problems of estimation. Math Proc Cambridge Philos Soc. 1948;44: 50–57. doi: 10.1017/S0305004100023987 [DOI] [Google Scholar]
- 53.Wald A. Tests of Statistical Hypotheses Concerning Several Parameters When the Number of Observations is Large. Trans Am Math Soc. 1943;54: 426. doi: 10.2307/1990256 [DOI] [Google Scholar]
- 54.Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B. 1995;57: 289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x [DOI] [Google Scholar]
- 55.Kraemer MUG, Sinka ME, Duda KA, Mylne A, Shearer FM, Brady OJ, et al. The global compendium of Aedes aegypti and Ae. albopictus occurrence. Sci Data. 2015;2: 1–8. doi: 10.1038/sdata.2015.35 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Vasilakis N, Tesh RB, Weaver SC. Sylvatic dengue virus type 2 activity in humans, Nigeria, 1966. Emerg Infect Dis. 2008;14: 502–504. doi: 10.3201/eid1403.070843 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Wang E, Ni H, Xu R, Barrett ADT, Watowich SJ, Gubler DJ, et al. Evolutionary Relationships of Endemic/Epidemic and Sylvatic Dengue Viruses. J Virol. 2000;74: 3227–3234. doi: 10.1128/jvi.74.7.3227-3234.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sudeep AB, Shil P. Aedes vittatus (Bigot) mosquito: An emerging threat to public health. J Vector Borne Dis. 2017;54: 295–300. doi: 10.4103/0972-9062.225833 [DOI] [PubMed] [Google Scholar]
- 59.Karger DN, Conrad O, Böhner J, Kawohl T, Kreft H, Soria-Auza RW, et al. Climatologies at high resolution for the earth’s land surface areas. Sci Data. 2017;4: 1–20. doi: 10.1038/sdata.2017.122 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Olson DM, Dinerstein E, Wikramanayake ED, Burgess ND, Powell GVN, Underwood EC, et al. Terrestrial Ecoregions of the World: A New Map of Life on Earth: A new global map of terrestrial ecoregions provides an innovative tool for conserving biodiversity. Bioscience. 2001;51: 933–938. doi: 10.1641/0006-3568(2001)051[0933:teotwa]2.0.co;2 [DOI] [Google Scholar]
- 61.FAO. GeoNetwork: Administrative Centres & Populated Places shapefile at the Relational World Database II (RWDB2). In: FAO [Internet]. 2000. Available: http://www.fao.org/geonetwork/srv/en/main.home
- 62.Legendre P. Spatial Autocorrelation: Trouble or New Paradigm? Ecology. 1993;74: 1659–1673. [Google Scholar]
- 63.Record S, Fitzpatrick MC, Finley AO, Veloz S, Ellison AM. Should species distribution models account for spatial autocorrelation? A test of model projections across eight millennia of climate change. Glob Ecol Biogeogr. 2013;22: 760–771. doi: 10.1111/geb.12017 [DOI] [Google Scholar]
- 64.World Health Organization. Geographical distribution of arthropod-borne diseases and their principal vectors. 1989. Available: http://www.who.int/iris/handle/10665/60575
- 65.Huang YM. Medical entomology studies—VIII. Notes on the taxonomic status of Aedes vittatus (Diptera: Culicidae). Am Entomol Inst. 1977;14: 113–132. [Google Scholar]
- 66.Zadeh LA. Fuzzy sets. Inf Control. 1965;8: 338–353. [Google Scholar]
- 67.Berger S. Dengue: Global Status. Los Angeles, California, USA: GIDEON Informatics, Inc.; 2015. [Google Scholar]
- 68.Real R, Olivero J, Vargas JM. Using chorotypes to deconstruct biogeographical and biodiversity patterns: the case of breeding waterbirds in Europe. Glob Ecol Biogeogr. 2008;17: 735–746. doi: 10.1111/j.1466-8238.2008.00411.x [DOI] [Google Scholar]
- 69.IUCN. IUCN Red List of Threatened Species. In: IUCN [Internet]. 2019. Available: https://www.iucnredlist.org/
- 70.Hurlbert AH, Jetz W. Species richness, hotspots, and the scale dependence of range maps in ecology and conservation. Proc Natl Acad Sci U S A. 2007;104: 13384–13389. doi: 10.1073/pnas.0704469104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Buser MW. Similarity of binary data. Syst Zool. 1976;25: 251–259. doi: 10.2307/2412493 [DOI] [Google Scholar]
- 72.Sneath Peter H. A., Sokal RR. Numerical Taxonomy The principles and practice of numerical classification. San Francisco: W. H. Freeman and Company; 1973. [Google Scholar]
- 73.Kreft H, Jetz W. A framework for delineating biogeographical regions based on species distributions. J Biogeogr. 2010;37: 2029–2053. doi: 10.1111/j.1365-2699.2010.02375.x [DOI] [Google Scholar]
- 74.Romero D, Olivero J, Brito JC, Real R. Comparison of approaches to combine species distribution models based on different sets of predictors. Ecography (Cop). 2016;39: 561–571. doi: 10.1111/ecog.01477 [DOI] [Google Scholar]
- 75.Muñoz AR, Real R, Barbosa AM, Vargas JM. Modelling the distribution of Bonelli’s eagle in Spain: implications for conservation planning. Divers Distrib. 2005;11: 477–486. doi: 10.1111/j.1366-9516.2005.00188.x [DOI] [Google Scholar]
- 76.Overgaard HJ, Olano VA, Jaramillo JF, Matiz MI, Sarmiento D, Stenström TA, et al. A cross-sectional survey of Aedes aegypti immature abundance in urban and rural household containers in central Colombia. Parasites and Vectors. 2017;10: 356. doi: 10.1186/s13071-017-2295-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Bombi P, D’Amen M. Scaling down distribution maps from atlas data: a test of different approaches with virtual species. J Biogeogr. 2012;39: 640–651. doi: 10.1111/j.1365-2699.2011.02627.x [DOI] [Google Scholar]
- 78.Lobo JM, Jiménez-Valverde A, Real R. AUC: A misleading measure of the performance of predictive distribution models. Glob Ecol Biogeogr. 2008;17: 145–151. doi: 10.1111/j.1466-8238.2007.00358.x [DOI] [Google Scholar]
- 79.Fielding AH, Bell JF. A review of methods for the assessment of prediction errors in conservation presence/absence models. Environ Conserv. 1997;24: 38–49. doi: 10.1017/S0376892997000088 [DOI] [Google Scholar]
- 80.Borcard D, Legendre P, Drapeau P. Partialling out the Spatial Component of Ecological Variation. Ecology. 1992;73: 1045–1055. doi: 10.2307/1940179 [DOI] [Google Scholar]
- 81.Muñoz AR, Real R. Assessing the potential range expansion of the exotic monk parakeet in Spain. Divers Distrib. 2006;12: 656–665. doi: 10.1111/j.1472-4642.2006.00272.x [DOI] [Google Scholar]
- 82.Hosmer DW, Lemeshow S. Applied Logistic Regression. Applied Logistic Regression. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2000. doi: 10.1002/0471722146 [DOI] [Google Scholar]
- 83.Mas-Coma S, Jones MK, Marty AM. COVID-19 and globalization. One Heal. 2020;9: 100132. doi: 10.1016/j.onehlt.2020.100132 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Bouzid M, Colón-González FJ, Lung T, Lake IR, Hunter PR. Climate change and the emergence of vector-borne diseases in Europe: Case study of dengue fever. BMC Public Health. 2014;14: 1–12. doi: 10.1186/1471-2458-14-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Schaffner F, Mathis A. Dengue and dengue vectors in the WHO European region: Past, present, and scenarios for the future. Lancet Infect Dis. 2014;14: 1271–1280. doi: 10.1016/S1473-3099(14)70834-5 [DOI] [PubMed] [Google Scholar]
- 86.Al-Abri SS, Kurup PJ, Al Manji A, Al Kindi H, Al Wahaibi A, Al Jardani A, et al. Control of the 2018–2019 dengue fever outbreak in Oman: A country previously without local transmission. Int J Infect Dis. 2020;90: 97–103. doi: 10.1016/j.ijid.2019.10.017 [DOI] [PubMed] [Google Scholar]
- 87.European Centre for Disease Prevention and Control. Communicable disease threats report CDTR Week 42, 13–19 October 2019. 2019.
- 88.European Centre for Disease Prevention and Control. Communicable disease threats report CDTR Week 41, 7–13 October 2018. 2018. Available: https://ecdc.europa.eu/sites/portal/files/documents/communicable-disease-threats-report-13-oct-2018.pdf
- 89.European Centre for Disease Prevention and Control. Communicable disease threats report CDTR Week 38, 15–21 September 2019. 2019.
- 90.Rivera A, Adams LE, Sharp TM, Lehman JA, Waterman SH, Paz-Bailey G. Travel-associated and locally acquired dengue cases—United States, 2010–2017. Morb Mortal Wkly Rep. 2020;69: 149–154. doi: 10.15585/mmwr.mm6906a1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Shinha T, Nautiyal P. Emerging Dengue Fever in New York City. Journal of Hospital Medicine. 2011. p. https://shmabstracts.org/abstra. Available: https://shmabstracts.org/abstract/emerging-dengue-fever-in-new-york-city/ [Google Scholar]
- 92.Olivero J, Toxopeus AG, Skidmore AK, Real R. Testing the efficacy of downscaling in species distribution modelling: a comparison between MaxEnt and Favourability Function models. Anim Biodivers Conserv. 2016;39: 99–114. doi: 10.32800/abc.2016.39.0099 [DOI] [Google Scholar]
- 93.Amarasinghe A, Kuritsky JN, William Letson G, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis. 2011;17: 1349–1354. doi: 10.3201/eid1708.101515 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Simmons CP, Farrar JJ, Van Vinh Chau N, Wills B. Dengue. N Engl J Med. 2012;366: 1423–1432. doi: 10.1056/NEJMra1110265 [DOI] [PubMed] [Google Scholar]
- 95.May R. Plagues and peoples. IUBMB Life. 2006. pp. 119–121. doi: 10.1080/15216540600686904 [DOI] [PubMed] [Google Scholar]
- 96.Almeida MAB, da Cardoso JC, dos Santos E, da Fonseca DF, Cruz LL, Faraco FJC, et al. Surveillance for Yellow Fever Virus in Non-Human Primates in Southern Brazil, 2001–2011: A Tool for Prioritizing Human Populations for Vaccination. PLoS Negl Trop Dis. 2014;8: e2741. doi: 10.1371/journal.pntd.0002741 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Smith CEG. The distribution of antibodies to Japanese encephalitis, dengue, and yellow fever viruses in five rural communities in Malaya. Trans R Soc Trop Med Hyg. 1958;52: 237–252. doi: 10.1016/0035-9203(58)90083-x [DOI] [PubMed] [Google Scholar]
- 98.Cardosa J, Ooi MH, Tio PH, Perera D, Holmes EC, Bibi K, et al. Dengue Virus Serotype 2 from a Sylvatic Lineage Isolated from a Patient with Dengue Hemorrhagic Fever. PLoS Negl Trop. 2009;3: e423. doi: 10.1371/journal.pntd.0000423 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Liu W, Pickering P, Duchêne S, Holmes EC, Aaskov JG. Highly Divergent Dengue Virus Type 2 in Traveler Returning from Borneo to Australia. Emerg Infect Dis. 2016;22: 2146–2148. doi: 10.3201/eid2212.160813 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Pyke AT, Moore PR, Taylor CT, Hall-Mendelin S, Cameron JN, Hewitson GR, et al. Highly divergent dengue virus type 1 genotype sets a new distance record. Sci Rep. 2016;6: 22356. doi: 10.1038/srep22356 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Rudnick A. Studies of the Ecology of Dengue in Malaysia: A Preliminary Report. J Med Entomol. 1965;2: 203–208. doi: 10.1093/jmedent/2.2.203 [DOI] [PubMed] [Google Scholar]
- 102.Yuwono J, Suharyono W, Koiman I, Tsuchiya Y, Tagaya I. Seroepidemiological survey on dengue and Japanese encephalitis virus infections in Asian monkeys. Southeast Asian J Trop Med Public Heal. 1984;15: 194–200. Available: https://pubmed.ncbi.nlm.nih.gov/6095461/ [PubMed] [Google Scholar]
- 103.Wolfe ND, Kilbourn AM, Karesh WB, Rahman HA, Bosi EJ, Cropp BC, et al. Sylvatic transmission of arboviruses among Bornean orangutans. Am J Trop Med Hyg. 2001;64: 310–316. doi: 10.4269/ajtmh.2001.64.310 [DOI] [PubMed] [Google Scholar]
- 104.Kading RC, Borland EM, Cranfield M, Powers AM. Prevalence of antibodies to alphaviruses and flaviviruses in free-ranging game animals and nonhuman primates in the greater Congo basin. J Wildl Dis. 2013;49: 587–599. doi: 10.7589/2012-08-212 [DOI] [PubMed] [Google Scholar]
- 105.Monlun E, Zeller H, Traore-Lamizana M, Hervy JP, Adam E, Mondo’ M, et al. Caractères cliniques et épidémiologiques de la dengue 2 au Sénégal. Med Mal Infect. 1992;22: 718–721. [Google Scholar]
- 106.Franco L, Palacios G, Martinez JA, Vázquez A, Savji N, de Ory F, et al. First report of sylvatic DENV-2-associated dengue hemorrhagic fever in West Africa. PLoS Negl Trop Dis. 2011;5: e1251. doi: 10.1371/journal.pntd.0001251 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Fagbami AH, Fabiyi A, Monath TP. Dengue virus infections in nigeria: A survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg. 1977;71: 60–65. doi: 10.1016/0035-9203(77)90210-3 [DOI] [PubMed] [Google Scholar]
- 108.Saluzzo JF, Cornet M, Adam C, Eyraud M, Digoutte JP. Dengue 2 in eastern Senegal: serologic survey in simian and human populations. 1974–85. Bull Soc Pathol Exot Fil. 1986;79: 313–322. Available: https://pubmed.ncbi.nlm.nih.gov/3769119/ [PubMed] [Google Scholar]
- 109.Diallo M, Ba Y, Sall AA, Diop OM, Ndione JA, Mondo M, et al. Amplification of the sylvatic cycle of dengue virus type 2, Senegal, 1999–2000: Entomologic findings and epidemiologic considerations. Emerg Infect Dis. 2003;9: 362–367. doi: 10.3201/eid0903.020219 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Eastwood G, Sang RC, Guerbois M, Taracha ELN, Weaver SC. Enzootic circulation of chikungunya virus in East Africa: Serological evidence in non-human Kenyan primates. Am J Trop Med Hyg. 2017;97: 1399–1404. doi: 10.4269/ajtmh.17-0126 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Patz JA, Daszak P, Tabor GM, Aguirre AA, Pearl M, Epstein J, et al. Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence. Environ Health Perspect. 2004;112: 1092–1098. doi: 10.1289/ehp.6877 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Allen T, Murray KA, Zambrana-Torrelio C, Morse SS, Rondinini C, Di Marco M, et al. Global hotspots and correlates of emerging zoonotic diseases. Nat Commun. 2017;8: 1–10. doi: 10.1038/s41467-016-0009-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Olivero J, Fa JE, Farfán M, Márquez AL, Real R, Juste FJ, et al. Human activities link fruit bat presence to Ebola virus disease outbreaks. Mamm Rev. 2020;50: 1–10. doi: 10.1111/mam.12173 [DOI] [Google Scholar]
- 114.Bloomfield LSP, McIntosh TL, Lambin EF. Habitat fragmentation, livelihood behaviors, and contact between people and nonhuman primates in Africa. Landsc Ecol. 2020;35: 985–1000. doi: 10.1007/s10980-020-00995-w [DOI] [Google Scholar]
- 115.Young KI, Mundis S, Widen SG, Wood TG, Tesh RB, Cardosa J, et al. Abundance and distribution of sylvatic dengue virus vectors in three different land cover types in Sarawak, Malaysian Borneo. Parasites and Vectors. 2017;10: 1–14. doi: 10.1186/s13071-016-1943-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Valentine MJ, Murdock CC, Kelly PJ. Sylvatic cycles of arboviruses in non-human primates. Parasites and Vectors. 2019;12: 1–18. doi: 10.1186/s13071-018-3256-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Morales MA, Fabbri CM, Zunino GE, Kowalewski MM, Luppo VC, Enría DA, et al. Detection of the mosquito-borne flaviviruses, West Nile, Dengue, Saint Louis Encephalitis, Ilheus, Bussuquara, and Yellow Fever in free-ranging black howlers (Alouatta caraya) of Northeastern Argentina. PLoS Negl Trop Dis. 2017;11: e0005351. doi: 10.1371/journal.pntd.0005351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Dolz G, Chaves A, Gutiérrez-Espeleta GA, Ortiz-Malavasi E, Bernal-Valle S, Herrero MV. Detection of antibodies against flavivirus over time in wild non-human primates from the lowlands of Costa Rica. PLoS One. 2019;14: 1–12. doi: 10.1371/journal.pone.0219271 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Catenacci LS, Ferreira M, Martins LC, De Vleeschouwer KM, Cassano CR, Oliveira LC, et al. Surveillance of Arboviruses in Primates and Sloths in the Atlantic Forest, Bahia, Brazil. Ecohealth. 2018;15: 777–791. doi: 10.1007/s10393-018-1361-2 [DOI] [PubMed] [Google Scholar]